Due to an editing oversight, a quote from Mark Stolorow, executive director of Orchid Cellmark, was truncated in last week’s issue of BioInform. The full quote is as follows: “We have adequate quality assurance controls in place to help us identify and correct any foreseeable quality assurance contingency. If I knew that it weren’t, I would correct it, so we operate under the assumption that we have adequate controls in place, and in the 16 year history of our company here at our Germantown site, that has been the case.”